Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg

Showing results (61-70 of 333) with videos related to

Pageof 34
Sort By:
Zeitschrift Fur Gastroenterologie|July 13, 2017
Epidemiology of hepatic encephalopathy in german hospitals - the EpHE studyChristian Labenz, Marcus-Alexander Wörns, Jörn M Schattenberg, et al.
JHEP Reports : Innovation in Hepatology|March 20, 2020
Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitisNigel Cook, Andreas Geier, Andreas Schmid, et al.
Digestive Diseases and Sciences|December 5, 2019
Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in GermanyChristian Labenz, Yvonne Huber, Maurice Michel, et al.
Hepatology (Baltimore, Md.)|October 30, 2018
Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic SteatohepatitisGeoff Farrell, Jörn M Schattenberg, Isabelle Leclercq, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2020
Proton pump inhibitors increase risk of bone fractures in men with cirrhosis: a population-based studyChristian Labenz, Marcus-Alexander Wörns, Charles C Adarkwah, et al.
Frontiers in Medicine|May 21, 2019
The Patient Perspectives on Future Therapeutic Options in NASH and Patient NeedsNigel Cook, Andreas Geier, Andreas Schmid, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 25, 2025
Impact of PNPLA3 I148M on Drug-Induced Hepatocellular Liver Injury: A Systematic Review and Meta-AnalysisAlexandra Gatzios, Lorna Marchandise, Hannes Hagström, et al.
Free Radical Biology & Medicine|March 13, 2012
The role of death effector domain-containing proteins in acute oxidative cell injury in hepatocytesJörn M Schattenberg, Marcus A Wörns, Tim Zimmermann, et al.
Hepatology Communications|September 14, 2020
Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and DepressionChristian Labenz, Yvonne Huber, Maurice Michel, et al.
European Journal of Gastroenterology & Hepatology|August 16, 2020
Liver injury in patients with severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysisChristian Labenz, Gerrit Toenges, Marcus-Alexander Wörns, et al.
Pageof 34

Showing results (61-70 of 333) with videos related to

Sort By:
Pageof 34
Zeitschrift Fur Gastroenterologie|July 13, 2017
Epidemiology of hepatic encephalopathy in german hospitals - the EpHE studyChristian Labenz, Marcus-Alexander Wörns, Jörn M Schattenberg, et al.
JHEP Reports : Innovation in Hepatology|March 20, 2020
Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitisNigel Cook, Andreas Geier, Andreas Schmid, et al.
Digestive Diseases and Sciences|December 5, 2019
Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in GermanyChristian Labenz, Yvonne Huber, Maurice Michel, et al.
Hepatology (Baltimore, Md.)|October 30, 2018
Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic SteatohepatitisGeoff Farrell, Jörn M Schattenberg, Isabelle Leclercq, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2020
Proton pump inhibitors increase risk of bone fractures in men with cirrhosis: a population-based studyChristian Labenz, Marcus-Alexander Wörns, Charles C Adarkwah, et al.
Frontiers in Medicine|May 21, 2019
The Patient Perspectives on Future Therapeutic Options in NASH and Patient NeedsNigel Cook, Andreas Geier, Andreas Schmid, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 25, 2025
Impact of PNPLA3 I148M on Drug-Induced Hepatocellular Liver Injury: A Systematic Review and Meta-AnalysisAlexandra Gatzios, Lorna Marchandise, Hannes Hagström, et al.
Free Radical Biology & Medicine|March 13, 2012
The role of death effector domain-containing proteins in acute oxidative cell injury in hepatocytesJörn M Schattenberg, Marcus A Wörns, Tim Zimmermann, et al.
Hepatology Communications|September 14, 2020
Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and DepressionChristian Labenz, Yvonne Huber, Maurice Michel, et al.
European Journal of Gastroenterology & Hepatology|August 16, 2020
Liver injury in patients with severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysisChristian Labenz, Gerrit Toenges, Marcus-Alexander Wörns, et al.
Pageof 34